Zeitlin, US
Alexander Semion Zeitlin, Rochester Hills, MI US
Patent application number | Description | Published |
---|---|---|
20080271538 | METHOD AND APPARATUS FOR EVALUATING NVH CHARACTERISTICS OF MECHANICAL SYSTEMS - A method and apparatus for evaluating NVH characteristics of a mechanical system including a torque-transmitting assembly having drive and driven members drivingly engaging each other. The torque-transmitting assembly is characterized by transmission error between the drive and driven members. The method comprises the steps of measuring a parameter representing NVH characteristics of the mechanical system during operation thereof upon a predetermined test cycle so as to obtain at least one NVH characteristic corresponding to at least two discrete values of the transmission error. The apparatus comprises a supporting member mounted to a casing for rotatably supporting the drive member and being axially movable relative to the casing so as to selectively adjust the transmission error, and an actuator assembly operatively associated with the supporting member for selectively adjusting position of the supporting member relative to the casing in order to selectively control the transmission error. | 11-06-2008 |
Andrew Zeitlin, Somerset, NJ US
Patent application number | Description | Published |
---|---|---|
20120148553 | METHODS OF GENERATING NATURAL KILLER CELLS - Provided herein are methods of producing natural killer cells using a two-step expansion and differentiation method. Also provided herein are methods of suppressing tumor cell proliferation, of treating individuals having cancer or a viral infection, comprising administering the NK cells produced by the method to an individual having the cancer or viral infection. | 06-14-2012 |
Andrew Zeitlin, Basking Ridge, NJ US
Patent application number | Description | Published |
---|---|---|
20100143312 | TREATMENT OF DISEASES, DISORDERS OR CONDITIONS OF THE LUNG USING PLACENTAL CELLS - Provided herein are compositions and methods of treatment of individuals having a disease, disorder or condition of the lung, comprising administering a therapeutically-effective amount of placental cells, e.g., placental stem cells. | 06-10-2010 |
20110280849 | TUMOR SUPPRESSION USING HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS AND IMMUNOMODULATORY COMPOUNDS - Provided herein are methods of suppressing tumor cell proliferation, of treating individuals having cancer or a viral infection, comprising contacting the tumor cells, or administering to the individual, placental perfusate, placental perfusate cells, or natural killer cells, e.g., placenta-derived intermediate natural killer cells, with an immunomodulatory compound or thalidomide. | 11-17-2011 |
20140093488 | TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS - Provided herein are placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof, to suppress the growth or proliferation of tumor cells, cancer cells, and the like, and to treat individuals having tumor cells. | 04-03-2014 |
20140341867 | TREATMENT OF STROKE USING ISOLATED PLACENTAL CELLS - Provided herein are methods for the treatment of stroke comprising administering to a stroke victim placental stem cells, populations of cells comprising placental stem cells, and/or compositions comprising placental stem cells. | 11-20-2014 |
20150072425 | METHODS OF GENERATING NATURAL KILLER CELLS - Provided herein are methods of producing natural killer cells using a two-step expansion and differentiation method. Also provided herein are methods of suppressing tumor cell proliferation, of treating individuals having cancer or a viral infection, comprising administering the NK cells produced by the method to an individual having the cancer or viral infection. | 03-12-2015 |
Andrew L. Zeitlin, Basking Ridge, NJ US
Patent application number | Description | Published |
---|---|---|
20100093797 | Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate - In one aspect, the present invention is directed to methods for treating fatigue, neurobehavioral slowing and other cognitive disorders and defects due to cancers and treatments associated with cancers, and similar conditions. In a further aspect, the present invention is directed to methods for treating disorders related to menopause, including executive function defects. The methods involve the administration of a composition comprising | 04-15-2010 |
20110257227 | Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate - In one aspect, the present invention is directed to methods for treating fatigue, neurobehavioral slowing and other cognitive disorders and defects due to cancers and treatments associated with cancers, and similar conditions. In a further aspect, the present invention is directed to methods for treating disorders related to menopause, including executive function defects. The methods involve the administration of a composition comprising D-threo methylphenidate that is substantially free of L-threo methylphenidate and of erythro forms of methylphenidate. | 10-20-2011 |
20130053414 | METHODS FOR TREATMENT OF COGNITIVE AND MENOPAUSAL DISORDERS WITH D-THREO METHYLPHENIDATE - In one aspect, the present invention is directed to methods for treating fatigue, neurobehavioral slowing and other cognitive disorders and defects due to cancers and treatments associated with cancers, and similar conditions. In a further aspect, the present invention is directed to methods for treating disorders related to menopause, including executive function defects. The methods involve the administration of a composition comprising | 02-28-2013 |
Andrew L. Zeitlin, Millington, NJ US
Patent application number | Description | Published |
---|---|---|
20090088455 | Chronic, Bolus Adminstration Of D-Threo Methylphenidate - Chronic bolus administration of D-threo methylphenidate is provided. The administration of the D-threo isomer eliminates adverse side effects associated with the DL racemate, and provides improved effectiveness. The compositions and methods of the invention are useful in treating nervous system disorders including attention deficit disorder, attention deficit hyperactivity disorder, and cognitive decline associated with systemic diseases such as acquired immunodeficiency syndrome. | 04-02-2009 |
20100035928 | Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate - Methods for treating Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, AIDS Dementia Complex and cognitive decline in HIV-AIDS while minimizing drug hypersensitivity, toxicity, side effects, euphoric effect, and drug abuse potential by administration of d-threo-methylphenidate or pharmaceutically acceptable salts thereof. | 02-11-2010 |
20110201645 | Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate - Methods for treating Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, AIDS Dementia Complex and cognitive decline in HIV-AIDS while minimizing drug hypersensitivity, toxicity, side effects, euphoric effect, and drug abuse potential by administration of d-threo-methylphenidate or pharmaceutically acceptable salts thereof. | 08-18-2011 |
20130109719 | METHOD OF TREATING ATTENTION DEFICIT DISORDERS WITH D-THREO METHYLPHENIDATE | 05-02-2013 |
Andy Zeitlin, Basking Ridge, NJ US
Patent application number | Description | Published |
---|---|---|
20100047213 | CELL COMPOSITION AND METHODS OF MAKING THE SAME - Provided herein are improved methods for the formulation of compositions comprising placental stem cells, and improved compositions and cell formulations produced thereby. | 02-25-2010 |
20100047351 | TREATMENT OF STROKE USING ISOLATED PLACENTAL CELLS - Provided herein are methods for the treatment of stroke comprising administering to a stroke victim placental stem cells, populations of cells comprising placental stem cells, and/or compositions comprising placental stem cells. | 02-25-2010 |
Eli Zeitlin, Bellevue, WA US
Patent application number | Description | Published |
---|---|---|
20130111462 | REACTIVE ANTI-TAMPERING SYSTEM | 05-02-2013 |
20150106478 | FILE HANDLERS SUPPORTING DYNAMIC DATA STREAMS - Various techniques for dynamically generating data streams from files are described herein. In one embodiment, a method includes receiving a request from an application to open a file. The request has a file identifier identifying the file, an attribute designator, and a data attribute delineated from the file identifier by the attribute designator. The method also includes retrieving data of at least a portion of the file based on the determined file identifier and dynamically generating a data stream of the file in response to the received request to open the file by transforming the retrieved data according to the data attribute of the request. The method further includes supplying the generated data stream to the application. | 04-16-2015 |
Eric S. Zeitlin, Baldwin, NY US
Patent application number | Description | Published |
---|---|---|
20090260168 | Corralling Utensil with Associated Cutting Board - A corralling utensil with associated cutting board ( | 10-22-2009 |
20100307008 | Knife Swiper - A removably attachable, multifunctional Knife Swiper ( | 12-09-2010 |
20100314814 | Compressible Corralling Utensil with Cutting Board - A corralling utensil with associated cutting board ( | 12-16-2010 |
Larry Zeitlin, Poway, CA US
Patent application number | Description | Published |
---|---|---|
20130149300 | MONOCLONAL ANTIBODIES WITH ALTERED AFFINITIES FOR HUMAN FCyRI, FCyRIIIa, AND C1q PROTEINS - Disclosed herein are GNGN and G1/G2 antibodies that recognize and bind various FcRs and C1 | 06-13-2013 |
Michael J. Zeitlin, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20140160128 | System and Method For Analyzing and Imaging Three-Dimensional Volume Data Sets Using a Three-Dimensional Sampling Probe - System and method for analyzing and imaging three-dimensional volume data sets using a three-dimensional sampling probe. A number of sampling probes can be created, shaped, and moved interactively by the user within the whole three-dimensional volume data set. As the sampling probe changes shape, size, or location in response to user input, the image is re-drawn at a rate sufficiently fast to be perceived as real-time by the user. In this manner, the user can more easily and effectively visualize and interpret the features and physical parameters that are inherent in the three-dimensional volume data set. | 06-12-2014 |
Nicolas Zeitlin, Berkeley, CA US
Patent application number | Description | Published |
---|---|---|
20150348533 | DOMAIN SPECIFIC LANGUAGE FOR ENCODING ASSISTANT DIALOG - Systems and processes for generating output dialogs for virtual assistants are provided. An output dialog can be generated from multiple output segments that can each include a string of one or more characters or words. The contents of an output segment can be selected from multiple possible outputs based on a predetermined order, conditional logic, or a random selection. The output segments can be concatenated to form the output dialog. In one example, a dialog generation file that defines the possible outputs for each output segment, an ordering of the output segments within the output dialog, and format for the output dialog can be used to generate the output dialog. The dialog generation file can include any number of functional blocks, which can each output an output segment, that can be arranged hierarchically and in a particular order to generate a desired output dialog. | 12-03-2015 |
Pamela L. Zeitlin, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20100222408 | Methods and Compositions for Treatment of Cystic Fibrosis - The present invention relates to compounds and methods of inhibiting p97/valosin-containing protein and compounds and methods of inhibiting gp78, the compounds and methods being useful for the treatment of a disorder comprising a IκB/NFκB mediated chronic inflammatory response component, for example cystic fibrosis. | 09-02-2010 |
Seth Zeitlin, Merrick, NY US
Patent application number | Description | Published |
---|---|---|
20090031242 | METHODS AND APPARATUS FOR PRESENTING A TARGETED PRESENTATION - Method and apparatus for presenting a recipient a recipient with a targeted presentation are described. An example method involves including a code in a first medium, including a first presentation in the first medium, and directing the recipient to a second medium related to the first presentation. At the second medium, the method requests the recipient to enter additional recipient information. The example method also involves storing the recipient information in a database, presenting the recipient with a second presentation about the first presentation, and including a third presentation based on the recipient information in a third medium | 01-29-2009 |